No high-level evidence for the suicide prevention through antidepressants or clozapine;Keine hochwertige Evidenz für Verhinderung von Suiziden durch Antidepressiva und Clozapin

Nervenarzt

Volumn 88, Issue 3, 2017, Pages 309-310

  Baethge, C ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CLOZAPINE; NEUROLEPTIC AGENT;

EVIDENCE BASED MEDICINE; LETTER; SUICIDE; HUMAN; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; HUMANS; SUICIDE; TREATMENT OUTCOME;

EID: 84986327400     PISSN: 00282804     EISSN: 14330407     Source Type: Journal    
DOI: 10.1007/s00115-016-0209-7     Document Type: Letter

References (6)

1. Haußmann R, Bauer M, Lewitzka U, Müller-Oerlinghausen B (2016) Psychopharmaka zur Behandlung suizidaler Patienten und zur Suizidprävention. Nervenarzt 87:483–487
2. Gibbons RD, Brown CH, Hur K, Davis JM, Mann JJ (2012) Suicidal thoughts and behavior with antidepressant treatment reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry 69:580–587
3. Braun C, Bschor T, Franklin J, Baethge C (2016) Suicides and suicide attempts during long-term treatment with antidepressants: a meta-analysis of 29 placebo-controlled studies including 6934 patients with major depressive disorder. Psychother Psychosom 85:171–179
4. Lewitzka U, Severus E, Bauer R, Ritter P, Müller-Oerlinghausen B, Bauer M (2015) The suicide prevention effect of lithium: more than 20 years of evidence-a narrative review. Int J Bipolar Disord 3:32
5. Lauterbach E, Felber W, Müller-Oerlinghausen B, Ahrens B, Bronisch T, Meyer T, Kilb B, Lewitzka U, Hawellek B, Quante A, Richter K, Broocks A, Hohagen F (2008) Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1‑year trial. Acta Psychiatr Scand 118:469–479
6. Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, Bourgeois M, Chouinard G, Islam MZ, Kane J, Krishnan R, Lindenmayer JP, Potkin S, International Suicide Prevention Trial Study Group (2003) Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 60(1):82–91